Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
Clinical trial NCT00035022 · COMPLETED
Trial details
- NCT number
- NCT00035022
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.